A Comprehensive Guide to Lipid Testing: Beyond the Standard Cholesterol Panel
- Cassie Wellock PA-C
- Feb 10
- 3 min read
Introduction: Why Lipid Testing Matters
When it comes to heart health, most traditional cholesterol tests fall short of providing a complete picture. The standard lipid panel (total cholesterol, LDL, HDL, and triglycerides) only gives us a basic snapshot of cholesterol. A comprehensive lipid workup evaluates lipoprotein particle size, insulin resistance markers, and inflammation levels to give a clearer picture of your cardiovascular health.
In this blog, we’ll break down what a comprehensive lipid panel should include and why each marker matters.
1. Standard Lipid Panel: The Basics
Most routine blood tests only include these four markers:
🔹 Total Cholesterol (TC): The sum of LDL, HDL, and other lipoproteins.🔹 Low-Density Lipoprotein (LDL-C): Often called "bad cholesterol," but total LDL alone isn’t the best predictor of risk.🔹 High-Density Lipoprotein (HDL-C): Known as "good cholesterol." 🔹 Triglycerides (TG): A type of fat in the blood that reflects metabolic health.
Why this isn’t enough:Total LDL doesn’t tell us how many LDL particles exist or how dangerous they are. A person with "normal" LDL-C but high LDL particle count (LDL-P) may still be at significant cardiovascular risk.
2. Advanced Lipid Markers: The Full Picture
A truly comprehensive lipid workup includes additional markers that more accurately reflect heart disease risk.
🔹 ApoB (Apolipoprotein B)
ApoB is a very important lipid metric for cardiovascular risk (this is the protein that specifically gets stuck in the endothelium of vasculature and can start plaque formation).
What It Measures: The total number of atherogenic (plaque-forming) lipoproteins, including LDL, VLDL, and Lp(a).
Optimal Range: Ideally < 90 mg/dL, lower is better
🔹 LDL-P (LDL Particle Count) – Number Matters More Than Size
Why It Matters: It’s not just LDL-C but how many LDL particles (LDL-P) exist that drives plaque buildup.
What It Measures: Total LDL particle concentration (measured via NMR or ApoB).
Risk Levels:
Optimal: < 1000 nmol/L
Borderline High: 1000-1299 nmol/L
High Risk: > 1600 nmol/L
🔹 LDL Size – Small vs. Large Particles
Why It Matters: Small, dense LDL particles are more atherogenic (higher risk of heart disease).
What It Measures: The proportion of small, dense LDL particles vs. large, buoyant LDL.
Risk Levels:
Pattern A (Large LDL – Low Risk)
Pattern B (Small, Dense LDL – High Risk)

3. Metabolic Health Markers: The Link Between Insulin Resistance & Lipids
Heart disease isn’t just about cholesterol—insulin resistance plays a huge role.
🔹 Triglyceride-to-HDL Ratio (TG/HDL) – Metabolic Health Indicator
Why It Matters: This ratio reflects insulin sensitivity and metabolic health.
What It Measures: The balance between stored fat (triglycerides) and protective HDL.
Optimal TG/HDL Ratio:
< 1.0 → Insulin-sensitive (low risk)
1.0 – 2.0 → Borderline risk
> 2.0 → High risk, likely insulin resistance
🔹 Fasting Insulin & HOMA-IR – Hidden Risks in Normal Blood Sugar
Why It Matters: Hyperinsulinemia (high fasting insulin) is an early driver of atherosclerosis.
What It Measures:
Fasting Insulin: lower is better.
HOMA-IR Score: Measures insulin resistance (calculated using fasting insulin & glucose).
4. Inflammation & Cardiovascular Risk Markers
Chronic inflammation accelerates plaque formation and heart disease risk.
🔹 hs-CRP (High-Sensitivity C-Reactive Protein) – Inflammation Marker
Why It Matters: Chronic inflammation worsens arterial damage.
What It Measures: General inflammation levels in the body.
Optimal Range:
Low risk: < 1.0 mg/L
Moderate risk: 1.0 – 3.0 mg/L
High risk: > 3.0 mg/L
🔹 Lp(a) – The Genetic Wildcard
Why It Matters: High Lp(a) = Increased cardiovascular risk, independent of LDL.
What It Measures: A genetically determined lipoprotein linked to early heart disease.
Risk Levels:
< 30 mg/dL → Low risk
> 50 mg/dL → High risk
Final Thoughts: Taking Control of Your Heart Health
A comprehensive lipid workup is far more powerful than a basic cholesterol test in predicting and preventing cardiovascular disease. By focusing on ApoB, LDL-P, insulin resistance markers, and inflammation, you can take proactive steps to reduce risk and optimize longevity.